tiprankstipranks
23andMe announces exploration of strategic alternatives
PremiumThe Fly23andMe announces exploration of strategic alternatives
1M ago
23andMe reports Q3 cont ops EPS ($1.02) vs. ($10.80) last year
Premium
The Fly
23andMe reports Q3 cont ops EPS ($1.02) vs. ($10.80) last year
1M ago
23andMe announces continued concerns regarding liquidity
Premium
The Fly
23andMe announces continued concerns regarding liquidity
1M ago
23andMe Reports Improved Financial Metrics Amid Revenue Decline
PremiumCompany Announcements23andMe Reports Improved Financial Metrics Amid Revenue Decline
4M ago
23andMe reports Q2 EPS ($2.32) vs ($3.17) last year
Premium
The Fly
23andMe reports Q2 EPS ($2.32) vs ($3.17) last year
4M ago
23andMe Cuts 40% of Staff, Shutters Drug Development Ahead of Q2 Print
Premium
Market News
23andMe Cuts 40% of Staff, Shutters Drug Development Ahead of Q2 Print
4M ago
23andMe Holding Expands Board with New Appointments
PremiumCompany Announcements23andMe Holding Expands Board with New Appointments
4M ago
23andMe appoints three new independent directors to board
Premium
The Fly
23andMe appoints three new independent directors to board
4M ago
23andMe Announces Reverse Stock Split and Strategic Adjustments
Premium
Company Announcements
23andMe Announces Reverse Stock Split and Strategic Adjustments
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100